Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data

MLA

Shichao Dong, and Chuan Sun. “Can Glucagon-like Peptide-1 Receptor Agonists Cause Acute Kidney Injury? An Analytical Study Based on Post-Marketing Approval Pharmacovigilance Data.” Frontiers in Endocrinology, vol. 13, Dec. 2022. EBSCOhost, https://doi.org/10.3389/fendo.2022.1032199.

APA

Shichao Dong, & Chuan Sun. (2022). Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.1032199

Chicago

Shichao Dong, and Chuan Sun. 2022. “Can Glucagon-like Peptide-1 Receptor Agonists Cause Acute Kidney Injury? An Analytical Study Based on Post-Marketing Approval Pharmacovigilance Data.” Frontiers in Endocrinology 13 (December). doi:10.3389/fendo.2022.1032199.